Senior management changes at Merck & Co
This article was originally published in Scrip
Merck & Co has announced changes to its senior management team: president of the global human health worldwide sales and marketing division Kenneth Frazier has been elected as company president, effective 1 May. He will report to the Merck's current chairman, CEO and president, Richard Clark, who will continue to lead the company as chairman and CEO. Adam Schechter, president of the company's pharmaceutical business in the US, has been elected to succeed Mr Frazier as president of global human health.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.